Barkley live questions Study guides, Class notes & Summaries

Barkley Acute Care Nurse Practitioner Certification Exam 172 Q & A Review Question Bank 1. A 59-year-old is having a follow-up evaluation two years after the successful conclusion of radiation therapy for leukemia. He tells you that he has been feeling run-down and reports unexplained weight loss and night sweats. Upon examination, you determine that he also has a fever and pain below his ribs and the left side. You know that he is at risk for chronic lymphotic leukemia. Which of the fo...

Barkley Live Questions and answers 2024 Patient with terminal cancer c/o breakthrough pain. They have 1 hydromorphone ER tab daily. A) Consider fentanyl patch B) Increase dose C) Start MSO4, stop hydromorphone D) Refer to pain specialist - A) Fentanyl is good for sustained release to help breakthrough pain. Do not refer for everything, need to do something. 62 y.o. Korean male with chest pain 5/10 x2 hours. He is silent, not answering questions openlywhy admit? A) Ethnicity B) H...

Barkley Live Questions and Answers (Graded A)Barkley Live Questions and Answers (Graded A)Barkley Live Questions and Answers (Graded A)Barkley Live Questions and Answers (Graded A)Patient with terminal cancer c/o breakthrough pain. They have 1 hydromorphone ER tab daily. A) Consider fentanyl patch B) Increase dose C) Start MSO4, stop hydromorphone D) Refer to pain specialist - ANSWER-A) Fentanyl is good for sustained release to help breakthrough pain. Do not refer for everything, nee...

Barkley Live Questions with 100% Correct Answers Patient with terminal cancer c/o breakthrough pain. They have 1 hydromorphone ER tab daily. A) Consider fentanyl patch B) Increase dose C) Start MSO4, stop hydromorphone D) Refer to pain specialist - Correct Answer ️️ -A) Fentanyl is good for sustained release to help breakthrough pain. Do not refer for everything, need to do something. 62 y.o. Korean male with chest pain 5/10 x2 hours. He is silent, not answering questions openly- w...

Patient with terminal cancer c/o breakthrough pain. They have 1 hydromorphone ER tab daily. A) Consider fentanyl patch B) Increase dose C) Start MSO4, stop hydromorphone D) Refer to pain specialist - Answer- A) Fentanyl is good for sustained release to help breakthrough pain. Do not refer for everything, need to do something. 62 y.o. Korean male with chest pain 5/10 x2 hours. He is silent, not answering questions openly- why admit? A) Ethnicity B) Hesitancy to discuss situat...

Barkley Live Questions And Answers With Verified Solutions Patient with terminal cancer c/o breakthrough pain. They have 1 hydromorphone ER tab daily. A) Consider fentanyl patch B) Increase dose C) Start MSO4, stop hydromorphone D) Refer to pain specialist A) Fentanyl is good for sustained release to help breakthrough pain. Do not refer for everything, need to do something. 62 y.o. Korean male with chest pain 5/10 x2 hours. He is silent, not answering questions openly- why admit?...

Patient with terminal cancer c/o breakthrough pain. They have 1 hydromorphone ER tab daily. A) Consider fentanyl patch B) Increase dose C) Start MSO4, stop hydromorphone D) Refer to pain specialist - Answer A) Fentanyl is good for sustained release to help breakthrough pain. Do not refer for everything, need to do something. 62 y.o. Korean male with chest pain 5/10 x2 hours. He is silent, not answering questions openly- why admit? A) Ethnicity B) Hesitancy to discuss situa...

Barkley Live Questions and Answers 2023 Correct

Barkley Live Questions with correct answers

Barkley Live Questions with 100% Correct Answers Patient with terminal cancer c/o breakthrough pain. They have 1 hydromorphone ER tab daily. A) Consider fentanyl patch B) Increase dose C) Start MSO4, stop hydromorphone D) Refer to pain specialist - Correct Answer ️️ -A) Fentanyl is good for sustained release to help breakthrough pain. Do not refer for everything, need to do something. 62 y.o. Korean male with chest pain 5/10 x2 hours. He is silent, not answering questions openly- w...

Barkley Live Questions and answers 2024.